Tianjin Ringpu Bio-Technology Co.,Ltd. (SHE:300119)

China flag China · Delayed Price · Currency is CNY
18.14
+0.10 (0.55%)
Apr 29, 2026, 3:04 PM CST
-4.07%
Market Cap 8.24B
Revenue (ttm) 3.40B
Net Income (ttm) 392.31M
Shares Out 454.07M
EPS (ttm) 0.86
PE Ratio 21.00
Forward PE 19.09
Dividend 0.40 (2.22%)
Ex-Dividend Date May 21, 2025
Volume 3,297,000
Average Volume 5,497,266
Open 18.15
Previous Close 18.04
Day's Range 17.94 - 18.28
52-Week Range 17.02 - 28.90
Beta 0.37
RSI 46.83
Earnings Date Mar 31, 2026

About SHE:300119

Tianjin Ringpu Bio-Technology Co.,Ltd. engages in the research and development, production, and sale of veterinary raw materials, pharmaceutical preparation, functional additives, and veterinary biological products. The company provides vaccines, chemical drugs, traditional Chinese medicines; feed additives, including pigs, chickens, waterfowl, cattle, sheep and pet medicines, and vaccines; and poultry, waterfowl, livestock, rumination, pets, washing and disinfection, active pharmaceutical ingredients product series. It also offers diagnosis an... [Read more]

Sector Healthcare
Founded 1998
Employees 2,900
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300119
Full Company Profile

Financial Performance

In 2025, SHE:300119's revenue was 3.40 billion, an increase of 10.70% compared to the previous year's 3.07 billion. Earnings were 400.51 million, an increase of 33.18%.

Financial Statements

News

There is no news available yet.